2-aminoadipic acid and methotrexate

2-aminoadipic acid has been researched along with methotrexate in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's6 (46.15)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K3
Kaneko, E; Mihara, M; Suzuki, T; Takagi, N; Takeda, Y1
Hiraoka, M; Mihara, M; Miyasaka, N; Takeda, Y1
Han, YH; Kato, Y; Sugiyama, Y2
Akamatsu, K; Kamatani, N; Kawamura, A; Mihara, M; Suzuki, T; Takeda, Y; Urakawa, K1
Asoh, Y; Han, YH; Kato, Y; Sugiyama, Y; Terao, K; Watanabe, Y1
Akamatsu, K; Kawamura, A; Mihara, M; Takagi, N; Takeda, Y; Urakawa, K1
Chen, JF; Cronstein, BN; Delano, D; Desai, A; Fink, JS; Jacobson, MA; Montesinos, MC1
Akabane, H; Komai, M; Masuda, T; Nagai, H; Nagao, K; Tanaka, H1
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Takashima, S; Tomoike, H1

Trials

1 trial(s) available for 2-aminoadipic acid and methotrexate

ArticleYear
A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
    International archives of allergy and immunology, 1997, Volume: 113, Issue:4

    Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Urea Nitrogen; Cell Division; Cholesterol; DNA, Single-Stranded; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Kidney Diseases; Lupus Nephritis; Lymph Nodes; Methotrexate; Mice; Mice, Inbred MRL lpr; Picrates; Proteinuria; Specific Pathogen-Free Organisms; Spleen

1997

Other Studies

12 other study(ies) available for 2-aminoadipic acid and methotrexate

ArticleYear
In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68.
    Immunopharmacology, 1996, Volume: 35, Issue:1

    Topics: 2-Aminoadipic Acid; Animals; Arthritis, Experimental; Cell Division; Cells, Cultured; Collagen; Endothelium, Vascular; Fibroblasts; Folic Acid Antagonists; Humans; Leukocytes, Mononuclear; Methotrexate; Mice; Polyglutamic Acid; Tetrahydrofolate Dehydrogenase

1996
Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).
    International journal of immunopharmacology, 1997, Volume: 19, Issue:2

    Topics: 2-Aminoadipic Acid; Age Factors; Animals; Autoantibodies; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Disease Models, Animal; Female; Folic Acid Antagonists; Graft vs Host Disease; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Mice; Mice, Inbred DBA; Mice, Inbred NZB; Proteinuria

1997
Immunosuppressive properties of MX-68, a novel unpolyglutamatable antifolate.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:10

    Topics: 2-Aminoadipic Acid; Animals; Cells, Cultured; Female; Folic Acid Antagonists; Hypersensitivity, Delayed; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Spleen

1997
A novel non-polyglutamable anti-folate, MX-68, inhibits the induction of experimental autoimmune uveitis in rats.
    Experimental eye research, 1998, Volume: 67, Issue:1

    Topics: 2-Aminoadipic Acid; Animals; Arrestin; Arthritis, Experimental; Autoimmune Diseases; Cell Division; Cells, Cultured; Collagen; Concanavalin A; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Immunization; Immunosuppressive Agents; Lymphocytes; Methotrexate; Rats; Rats, Inbred Strains; Uveitis

1998
Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:1

    Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Anion Transport Proteins; Binding Sites; Carrier Proteins; Cell Membrane; Cytosol; Dose-Response Relationship, Drug; Folic Acid Antagonists; Ion Transport; Kidney Cortex; Liver; Male; Metabolic Clearance Rate; Methotrexate; Microvilli; Rats; Rats, Sprague-Dawley; Tissue Distribution

1999
Binding and transport of methotrexate and its derivative, MX-68, across the brush-border membrane in rat kidney.
    Biopharmaceutics & drug disposition, 1999, Volume: 20, Issue:8

    Topics: 2-Aminoadipic Acid; Animals; Biological Transport; Dose-Response Relationship, Drug; Folic Acid; Folic Acid Antagonists; Hydrogen-Ion Concentration; Kidney; Male; Methotrexate; Microvilli; Osmolar Concentration; Rats; Rats, Sprague-Dawley

1999
Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects.
    Immunopharmacology, 2000, Jul-20, Volume: 48, Issue:2

    Topics: 2-Aminoadipic Acid; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Line; Extracellular Space; Female; Folic Acid Antagonists; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Pteroylpolyglutamic Acids

2000
Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2001, Volume: 29, Issue:4 Pt 1

    Topics: 2-Aminoadipic Acid; Animals; Anion Transport Proteins; Anions; Antimetabolites; Biological Transport; Carrier Proteins; Cells, Cultured; Drug Carriers; Folic Acid; Folic Acid Antagonists; Glutathione; Hepatocytes; Hydrogen-Ion Concentration; Male; Methotrexate; Rats; Sodium; Time Factors; Transport Vesicles; Tritium

2001
Polyglutamation of a novel antifolate, MX-68, is not necessary for its anti-arthritic effect.
    European journal of pharmacology, 2002, Jan-25, Volume: 435, Issue:2-3

    Topics: 2-Aminoadipic Acid; Animals; Antineoplastic Agents; Antirheumatic Agents; Arthritis, Experimental; Cell Division; Cells, Cultured; Disease Models, Animal; Folic Acid Antagonists; Male; Methotrexate; Mice; Mice, Inbred DBA; Peptide Synthases; Polyglutamic Acid; Rats; Rats, Inbred Lew; Substrate Specificity; Tetrahydrofolate Dehydrogenase

2002
Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:1

    Topics: 2-Aminoadipic Acid; Acute Disease; Animals; Antirheumatic Agents; Arthritis; Methotrexate; Mice; Mice, Knockout; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha

2003
Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs.
    The Journal of pharmacy and pharmacology, 2004, Volume: 56, Issue:2

    Topics: 2-Aminoadipic Acid; Acetylcholine; Administration, Inhalation; Allergens; Animals; Body Weight; Bronchial Hyperreactivity; Bronchitis; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Immunoglobulins; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Methotrexate; Mice; Mice, Inbred BALB C; Ovalbumin; Prednisolone

2004
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
    Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:4

    Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline

2004